CLASS II Drug recall · Reported 15 Apr 2015 · FDA Enforcement Report

Ketorolac Tromethamine Inj., USP, 60 mg recalled by Hospira

Hospira is recalling Ketorolac Tromethamine Inj., USP, 60 mg (30 mg/mL) Fill Single-dose Vials, I.V/I.M. USE, distributed nationwide in the US. The recall was initiated on 23 Jan 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesNDC 0409-3796-01, Lot number: 26-098-DK, Exp. Date:1FEB2015; Lot number: 29-239-DK, 29-240-DK, Exp. Date:1MAY2015; Lot number: 34-540-DK, Exp. Date:1OCT2015; Lot number: 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, Exp. Date:1JAN2016; Lot number: 41-282-DK, 41-284-DK, Exp. Date:1MAY2016; Lot number: 44-076-DK, Exp. Date:1AUG2016; Lot number: 45-240-DK, Exp. Date:1SEP2016 and Lot number: 46-306-DK, Exp. Date:1OCT2016 AND NOVAPLUS label NDC 0409-3796-49, Lot number: 26-097-DK, Exp. Date:1FEB2015.
NDC0409-3793, 0409-3795, 0409-3796
Quantity recalledHOSPIRA = 4,339,500 vials. NOVAPLUS = 341,100 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0483-2015
FDA event ID
70515
Recalling firm
Hospira, Lake Forest, IL
Manufacturer
Hospira, Inc.
Classification
Class II
Status
Terminated
Recall initiated
23 Jan 2015
FDA classified
8 Apr 2015
Reported
15 Apr 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Pain Medication

Timeline

23 Jan 2015Recall initiated by company
8 Apr 2015Classified by FDA+75 days
15 Apr 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Crystallization

Product as listed by the FDA

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Where it was distributed

U.S. Nationwide and International: Guam and Singapore.

Nationwide

Questions about this recall

Why was it recalled?

Crystallization

Which lots are affected?

NDC 0409-3796-01, Lot number: 26-098-DK, Exp. Date:1FEB2015; Lot number: 29-239-DK, 29-240-DK, Exp. Date:1MAY2015; Lot number: 34-540-DK, Exp. Date:1OCT2015; Lot number: 37-037-DK, 37-038-DK, 37-147-DK, 37-148-DK, 37-228-DK, 37-282-DK, Exp. Date:1JAN2016; Lot number: 41-282-DK, 41-284-DK, Exp. Date:1MAY2016; Lot number: 44-076-DK, Exp. Date:1AUG2016; Lot number: 45-240-DK, Exp. Date:1SEP2016 and Lot number: 46-306-DK, Exp. Date:1OCT2016 AND NOVAPLUS label NDC 0409-3796-49, Lot number: 26-097-DK, Exp. Date:1FEB2015.

Where was it sold?

U.S. Nationwide and International: Guam and Singapore.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 70515
ReportedClassRecallCompanyReasonWhere
CLASS IIKetorolac Tromethamine Inj., USP, 30 mg (30 mg/mL) Fill recalledKetorolac TromethamineHospiraOtherNationwide

More recalls from Hospira

All 225

Other Ketorolac Tromethamine recalls

All 24